Skip to main content
. 2021 Apr 8;22(4):280–287. doi: 10.1177/17511437211010031

Table 2.

Underling comorbidities of participants at enrolment.

Cardiovascular disease 19 (55.9%)
Chronic lung disease 4 (11.8%)
Cancer 4 (11.8%)
Chronic kidney disease 3 (8.8%)
Chronic liver disease 7 (20.6%)
Immunosuppressed 5 (14.7%)